Detalhe da pesquisa
1.
Real-world outcomes of adult patients with acute lymphoblastic leukemia treated with a modified CALGB 10102 regimen.
Ann Hematol
; 102(4): 897-906, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36856803
2.
BRIVEST: A 'real-world' observational, single-centre study investigating the efficacy, safety and tolerability of Brivaracetam.
Epilepsy Behav
; 138: 108985, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36442261
3.
Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML).
Ann Hematol
; 93(1): 47-55, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24149914
4.
Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia.
Nat Commun
; 13(1): 1673, 2022 03 30.
Artigo
Inglês
| MEDLINE | ID: mdl-35354808
5.
Efficacy of 10-day decitabine in acute myeloid leukemia.
Leuk Res
; 103: 106524, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33640708
6.
A Pilot Phase II Study of the Feasibility and Efficacy of Vincristine Sulfate Liposome Injection in Patients With Relapsed or Refractory Acute Myeloid Leukemia.
J Hematol
; 10(1): 1-7, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-33643502
7.
The prognostic value of standardized phase angle in adults with acute leukemia: A prospective study.
Cancer Med
; 9(7): 2403-2413, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32049445
8.
A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia.
Clin Cancer Res
; 24(9): 2060-2073, 2018 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29437791
9.
Priapism in the oncology setting.
Clin J Oncol Nurs
; 11(1): 23-5, 2007 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-17441393
10.
Re-induction therapy in adult patients with acute myeloid leukemia with ≤20 % blasts: A retrospective cohort study.
Leuk Res
; 111: 106731, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34695644
11.
High dose cytarabine, mitoxantrone and l-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly.
Leuk Res
; 39(9): 945-9, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26154683
12.
A phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies.
Clin Cancer Res
; 20(20): 5255-64, 2014 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25165100